Regional Anesthesia and Lung Cancer Recurrence

Stopped early · Not applicable

Conditions studied: Lung Cancer

In brief

Test the effect of combined regiona/general anesthesia on lung cancer recurrence compared to general anesthesia alone.

Key facts

Study ID

NCT01179308

Run by

The Cleveland Clinic

People needed

67

Starts

2010-08-01

Expected to finish

2015-08-01

Last updated by the study team

2016-09-15

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Primary non-small cell lung cancer (stage 1-3) as determined according to the IASLC Lung Cancer Staging Project;
• Scheduled for potentially curative tumor resection;
• Written informed consent, including willingness to be randomized to epidural anesthesia/analgesia plus general anesthesia or to general anesthesia and postoperative opioid analgesia.

You may not qualify if…

• Any contraindication to epidural anesthesia, (including coagulopathy, abnormal anatomy).
• Any contraindication to midazolam, propofol, sevoflurane, fentanyl, morphine, or hydromorphone.
• Age < 18 or > 85 years old.
• Other cancer not believed by the attending surgeon to be in long-term remission.

Where it is running

• Cleveland Clinic — Cleveland, Ohio, United States
• Shanghai Chest Hospital — Shanghai, China

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.